Literature DB >> 3544984

Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study.

T Kolobow, M P Moretti, R Fumagalli, D Mascheroni, P Prato, V Chen, M Joris.   

Abstract

We explored the pulmonary effects of continuous mechanical ventilation (MV) at a peak inspiratory pressure of 50 cm H2O in healthy, paralyzed, and anesthetized adult sheep during a period of 48 h. The 9 control sheep (Group A) were ventilated with 40% oxygen at a tidal volume of about 10 ml/kg and a peak inspiratory pressure of 15 to 20 cm H2O. All these animals remained stable throughout the 48 h of MV with no change in lung function. The 7 sheep in Group B were ventilated with 40% oxygen using a pressure-controlled ventilator at 50 cm H2O peak inspiratory pressure, at a VT of 50 to 70 ml/kg. All sheep in Group B developed severe respiratory failure and died or were killed within 2 to 35 h, and showed parenchymal consolidation at autopsy. The 9 sheep in Group C were ventilated as in Group B, except that 3.8% CO2 was added to the inspired gases: the Group C animals deteriorated more slowly, with little change in PaO2 but with a severely reduced FRC, VT, total static lung compliance, and grossly abnormal lungs at autopsy. We conclude that in this model, mechanical ventilation at peak airway pressure of 50 cm H2O will lead to progressive impairment in pulmonary mechanics, lung function, acute respiratory failure, and alveolar cellular dysfunction, as demonstrated by highly abnormal minimal surface tension values of saline lung lavage fluid in both study groups.

Entities:  

Mesh:

Year:  1987        PMID: 3544984     DOI: 10.1164/arrd.1987.135.2.312

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  75 in total

1.  Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Vedang Londhe; Ying Ying Xue; Kewang Li; Roderick J Phillips; Robert M Strieter
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  The pulmonary physician in critical care * 7: ventilator induced lung injury.

Authors:  T Whitehead; A S Slutsky
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

3.  PEEP, ARDS, and alveolar recruitment.

Authors:  J Mancebo
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 4.  The pulmonary physician and critical care. 2. The injured lung: conventional and novel respiratory therapy.

Authors:  A Swami; B F Keogh
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

5.  Extracorporeal lung assist for two cases of severe acute respiratory failure.

Authors:  K Tsuno; H Terasaki; T Okamoto; R Tsutsumi; T Morioka; T Katsuya
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

6.  Modeling the time-course of ventilator-induced lung injury: what can we learn from interspecies discrepancies?

Authors:  Nicolas de Prost; Georges Saumon; Didier Dreyfuss
Journal:  Intensive Care Med       Date:  2011-11-04       Impact factor: 17.440

7.  Time to generate ventilator-induced lung injury among mammals with healthy lungs: a unifying hypothesis.

Authors:  Pietro Caironi; Thomas Langer; Eleonora Carlesso; Alessandro Protti; Luciano Gattinoni
Journal:  Intensive Care Med       Date:  2011-11-04       Impact factor: 17.440

8.  Transpulmonary pressure as a surrogate of plateau pressure for lung protective strategy: not perfect but more physiologic.

Authors:  Jean-Christophe M Richard; John J Marini
Journal:  Intensive Care Med       Date:  2012-02-10       Impact factor: 17.440

9.  Target blood gases during ARDS ventilatory management.

Authors:  A Pesenti
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

10.  Evaluation of Ventilation-Induced Lung Inflammation Through Multi-Scale Simulations.

Authors:  Israr Bin M Ibrahim; Ramana M Pidaparti; Kevin R Ward
Journal:  IEEE J Transl Eng Health Med       Date:  2017-12-27       Impact factor: 3.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.